Skip to content

Randomized clinical study of electrophysiologically guided external diaphragmatic pacing on diaphragm functions and outcomes of critically ill patients

Randomized clinical study of electrophysiologically guided external diaphragmatic pacing on diaphragm functions and outcomes of critically ill patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075858
Enrollment
Unknown
Registered
2023-09-18
Start date
2023-05-31
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically ill patients

Interventions

Experimental group:Electrophysiologically guided external diaphragmatic pacing
Control group:External diaphragmatic pacing

Sponsors

Zhongda Hospital, Affiliated to Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1: Aged 18 to 75 years old 2: Mechanical ventilation time > 24h, and expected to continue mechanical ventilation time > 5 days 3: RASS score =1 point and stable vital signs (inhaled oxygen concentration FiO2=60%, respiratory rate RR=35 times /min, heart rate HR=120/min, systolic blood pressure 90-160mmHg, SpO2=90%) 4: All patients or their families have informed consent and signed an informed consent form

Exclusion criteria

Exclusion criteria: 1: There are clear contraindications to the use of EDP, such as cardiac implantable pacemaker, pneumothorax, etc. 2: Incomplete neck skin, catheterization through internal jugular vein, and untreated internal jugular vein thrombosis 3: Unclear ultrasound imaging, such as obesity (BMI=40 kg/m2) 4: The conduction of phrenic nerve indicated that the stimulation current was > 50mA when diaphragm CMAP did not elicit or elicited waveforms after phrenic nerve stimulation 5: Neuromuscular disorders that are currently being treated with neuromuscular blockade or that affect respiratory muscles 6: The patient may survive for less than 72h due to his own disease; 7: Patients with tumor or pregnancy 8: Patients voluntarily withdraw

Design outcomes

Primary

MeasureTime frame
Diaphragm thickening fraction;Diaphragm movement;

Secondary

MeasureTime frame
Time to weaning;Neuroelectrophysiological detection;Success rate/survival rate of weaning within 28 days;IMS score;MRC score;Arterial blood gas analysis;

Countries

China

Contacts

Public ContactZhengyong Hu

Zhongda Hospital, Affiliated to Southeast University

624264057@qq.com+86 159 5046 9355

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026